A
Adaptimmune - ADR (ADAP)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adaptimmune - ADR (ADAP)
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more
- USD0.47
- USD0.48
- USD0.42
- USD2.38
- -13.60%
- 58M
- 363.32k
- 429.42k
- 106M
- 0.42
- -78.40%
Stock News
57 minutes ago
Dow Jones Newswires: China’s Meituan plans share buyback valued at up to $1 billion
MarketWatch
yesterday
Key Words: 9 of Charlie Munger’s best investing lessons and words of wisdom
MarketWatch
yesterday
FA Center: ‘Wealth is really relative in the eyes of the beholder.’ You may not be as rich (or poor) as you think.
MarketWatch
yesterday
Market Extra: GameStop stock’s best day since January driven by fresh wave of speculative bets
MarketWatch
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
